Why I Don't Use Vitamin C Derivatives — The Data Made Me Stop
Every Brand Sells Derivatives — Here's Why Phyto-C Never Has
Vitamin C derivatives formulation science is one of the most marketing-saturated corners of the entire skincare industry — and that is exactly why I want to address it directly. When I rebuilt Phyto-C after 2014, I was not starting from trend reports. I was starting from the NCI-funded research that originally established this company — research built entirely on L-ascorbic acid as the bioactive form of vitamin C. Every formulation decision I made came from that foundation.
The industry pressure to switch to derivatives is real and has been relentless for nearly two decades. Derivatives are stable in the bottle. They are easier to manufacture. They photograph well in a clear serum. They do not turn orange on the shelf. Brands can charge a premium while spending less on the formulation challenge. I understand every one of those incentives — I run a company. But my training is in pharmacognosy and pharmaceutical sciences, and that training taught me to ask one question before anything else: does this molecule reach its site of activity in a biologically meaningful concentration? For vitamin C derivatives, the peer-reviewed literature has never given me a satisfying answer.
What Does "Stable" Really Mean — and Why Is It the Wrong Goal?
Stability in the bottle tells you something useful about shelf life. It tells you nothing about biological activity at the receptor site. This distinction is fundamental in pharmaceutical sciences and almost entirely absent from the way the skincare industry communicates about vitamin C.
Ascorbyl glucoside, magnesium ascorbyl phosphate (MAP), and ascorbyl palmitate are stable precisely because they are not ascorbic acid. They are chemically distinct molecules. The glucose group in ascorbyl glucoside, the phosphate group in MAP, the palmitate chain in ascorbyl palmitate — these modifications confer stability. They also mean the molecule must be enzymatically cleaved before the skin can use ascorbic acid in any capacity. You are not applying vitamin C. You are applying a precursor and hoping the skin converts it.
Human skin has measurable glucosidase and phosphatase activity, but it is not a bioreactor optimized for this conversion. The activity is limited, variable between individuals, and concentrated in specific cell populations. Stability in formulation is a manufacturing convenience — not a clinical benefit, and it should not be presented as one.
Does Published Research Support Vitamin C Derivatives Over L-Ascorbic Acid?
The short answer is no. When researchers have measured actual ascorbate levels in skin tissue following topical application, L-ascorbic acid formulated at acidic pH consistently produces higher measurable concentrations than derivative-based products. The bioconversion literature for vitamin C derivatives is inconsistent and often studied under conditions that do not replicate topical skin application.
Most in vitro studies showing conversion use isolated enzyme systems at pH and temperature conditions not representative of the stratum corneum environment. Ascorbyl glucoside is the derivative I am most frequently asked about because it has been marketed aggressively as a "next-generation" vitamin C. What is rarely disclosed is that ascorbyl glucoside requires a two-step enzymatic cleavage to yield free ascorbic acid. First, maltase or glucoamylase must cleave the glucose bond; then the resulting intermediate must be further processed. Each enzymatic step introduces yield loss. In a biological system with limited and variable enzyme availability, cumulative conversion efficiency under real-world application conditions is not well characterized — and studies that do attempt to characterize it show wide variability.
The research that founded Phyto-C was specifically designed around L-ascorbic acid because it is the bioactive form. No conversion is required. No enzymatic efficiency is assumed. The molecule that reaches the skin is the molecule the skin can use. That logic has not changed, and the derivative literature has not produced evidence that would change it.
L-Ascorbic Acid vs. Common Vitamin C Derivatives: A Direct Comparison
| Property | L-Ascorbic Acid | Ascorbyl Glucoside | MAP (Magnesium Ascorbyl Phosphate) | Ascorbyl Palmitate |
|---|---|---|---|---|
| Bioactive form of vitamin C | Yes — no conversion needed | No — two-step enzymatic cleavage required | No — phosphatase cleavage required | No — esterase cleavage required |
| Conversion efficiency in skin | N/A (already active) | Low and variable; not well characterized | Moderate; strongest derivative record | Low; also shows pro-oxidant risk |
| Formulation stability | Narrow — requires low pH, controlled packaging | High — stable at neutral pH | High — stable at neutral pH | High in oil phase |
| Known oxidative risk | Oxidizes if improperly packaged | Low | Low | Pro-oxidant under UV + iron exposure |
| Used in Phyto-C formulations | Yes — exclusively | No | No | No |
What I Do Instead — and What It Costs Me
I want to be honest about the trade-off, because scientists should be honest about what their choices actually cost them. Formulating with L-ascorbic acid at low pH is genuinely difficult. The stability window is narrow. Oxidation is a real formulation risk. pH must be tightly controlled. Packaging is not an afterthought — it is a functional variable. An L-ascorbic acid serum in a clear dropper bottle sitting in sunlight is not the same product it was when it left my lab. These are not theoretical concerns. They are problems I have spent years solving.
My approach to stabilization uses bioflavonoid co-antioxidants rather than ferulic acid. I want to address the ferulic acid question directly because I know it contradicts what much of the industry promotes. Lee et al. (2005, Archives of Pharmacal Research) demonstrated NADPH oxidase-mediated reactive oxygen species generation with ferulic acid — a pro-oxidant mechanism I consider an unacceptable risk in a vitamin C formulation designed to support antioxidant defense. I have never used ferulic acid in a Phyto-C product and I do not intend to. Bioflavonoids provide co-antioxidant synergy without that risk.
Beyond ingredient selection, I use pH-engineered aqueous systems and opaque UV-protective packaging on every vitamin C product. The derivative alternative is more forgiving — you can use a clear bottle, a higher pH, a less controlled manufacturing environment. The business case for derivatives is straightforward. The scientific case, in my view, is not.
Every Phyto-C vitamin C serum delivers L-ascorbic acid directly because that is what the clinical evidence supports. Entry-level options include E in C Lite (10% L-ascorbic acid with vitamin E, designed for sensitive skin and vitamin C beginners) and Serum Fifteen (15% L-ascorbic acid, simple formula, no alcohol). For those ready for maximum concentration, Serum Twenty delivers 20% L-ascorbic acid in the same clean base. Advanced users combining vitamin C with retinol can explore Selenium in C Serum, which layers L-ascorbic acid, retinol, vitamin E, and selenium in a single formulation. I am not willing to compromise on the active form of the molecule to make my job easier.
Frequently Asked Questions About Vitamin C Derivatives
Isn't ascorbyl glucoside gentler and better for sensitive skin?
The "gentler" argument for ascorbyl glucoside is based on its higher pH compared to L-ascorbic acid formulations. A molecule that does not convert efficiently to ascorbic acid in the skin is not a gentler option — it is a less effective one. Sensitive skin can generally tolerate well-formulated L-ascorbic acid serums when concentration and pH are appropriate. The irritation concern is more often about formulation quality than the active itself. Phyto-C's E in C Lite was specifically developed as a lower-concentration (10%) L-ascorbic acid entry point for sensitive skin.
Do any vitamin C derivatives have legitimate clinical evidence behind them?
Some derivatives have peer-reviewed studies showing cosmetic appearance benefits in controlled settings. MAP has arguably the strongest published record among the derivatives. However, when studies compare derivatives directly against L-ascorbic acid at equivalent concentrations and appropriate pH, L-ascorbic acid consistently produces superior outcomes in bioavailability measurements. The clinical evidence for derivatives exists — but it does not surpass the evidence for the bioactive form.
Why do so many dermatologists recommend derivative-based products if they don't work as well?
Dermatologists are generally excellent clinicians, but formulation science is not always part of clinical training. Many recommendations are based on patient tolerance, brand familiarity, or published studies that did not include a direct L-ascorbic acid comparator. This reflects the gap between cosmetic chemistry and clinical dermatology — a real and persistent problem in how skincare science is communicated to practitioners and consumers alike.
What is the conversion rate of ascorbyl glucoside to L-ascorbic acid in skin?
Published conversion rates vary significantly depending on the enzyme system used, pH conditions, and whether the study was conducted in vitro or ex vivo. Under conditions designed to replicate topical application, conversion efficiency is inconsistent and often incomplete. No published data has established a reliable, therapeutically meaningful conversion rate under real-world application conditions sufficient to justify preferring ascorbyl glucoside over L-ascorbic acid as a primary vitamin C source.
Is ascorbyl palmitate a good vitamin C source for skin?
Ascorbyl palmitate is oil-soluble and is sometimes used in emulsion systems as a combined vitamin C source and antioxidant preservative. However, peer-reviewed data suggests ascorbyl palmitate can behave as a pro-oxidant under certain conditions, particularly in the presence of iron and UV exposure. Phyto-C does not use ascorbyl palmitate in any formulation. Its bioconversion profile and oxidative risk profile make it a poor choice as a primary vitamin C source in an antioxidant-support formulation.
Which Phyto-C products use pure L-ascorbic acid?
Every Phyto-C vitamin C product is formulated exclusively with L-ascorbic acid — never a derivative. The range includes Serum Fifteen (15%), Serum Twenty (20%), E in C Lite (10% with vitamin E), E in C Advanced (20% with vitamin E), Selenium in C Serum (15% with retinol and selenium), and Eye Return Gel (7.5% for the eye area). No Phyto-C formulation has ever contained a vitamin C derivative.
The science on this question has been clear to me since I began formulating: L-ascorbic acid is the bioactive form of vitamin C, and no derivative has produced evidence compelling enough to change that position. To see what a fully committed L-ascorbic acid formulation looks like in practice, explore the full range — from E in C Lite for sensitive skin beginners to Serum Twenty at maximum concentration — built on the same scientific foundation that has guided Phyto-C from the beginning.


My Account
Our Story
Shipping Information
Returns
FAQ
VIP Rewards
Contact Us
Next Post